Biotech BB vs Biotech HF 1-3 billion fund.
Ultimate goal is HF, but I've heard the training in BBs goes a long way. BB is also less risk averse. What is the better choice here? BB is middle of the pack, but does well in the space.
Ultimate goal is HF, but I've heard the training in BBs goes a long way. BB is also less risk averse. What is the better choice here? BB is middle of the pack, but does well in the space.
| +374 | Which Offer to Accept: UBS Analyst Role or Part Time Cashier at the Local Taco Bell | 44 | 6h |
| +291 | Roku-Fox Deal - UBS Misses Out on yet another deals after years chasing this deal | 31 | 6h |
| +272 | TPH V.S. Mizuho [HOU] | 33 | 2h |
| +270 | AI is insane | 38 | 2h |
| +268 | I Snuck Into UBS Office And Took A Shit On The Floor | 26 | 9h |
| +220 | Best Power/Renewables/Energy Teams? | 35 | 4h |
| +202 | Useless associates | 36 | 5h |
| +184 | Differences in Restructuring Teams? | 33 | 6h |
| +181 | Centerview HC group falling off? | 28 | 6h |
| +181 | Actual EB List | 26 | 3h |
Career Resources
more risk averse*
Go with the BB.
Rationale?
Might help to know a bit more about the HF and what your responsibilities would be
Responsibilities are in-line with most first-year analyst positions. It's a L/S fund that invests in primarily biotech. It's 10-15 years old. I would cover therapeutic areas.
Ea sit nesciunt rerum voluptatum maiores nulla. Repudiandae consequuntur ut nesciunt iure.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...